Correlation of DNA mismatch repair protein hMSH2 immunohistochemistry with p53 and apoptosis in cervical carcinoma

Anticancer Research

Volumn 27, Issue 1 A, 2007, Pages 63-68

  Köster, Frank ^a   Schröer, Andreas ^a   Fischer, Dorothea ^a   Greweldinger, Thomas ^b   Diedrich, Klaus ^a   Friedrich, Michael ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cervical cancer; DNA mismatch repair; hMSH2; Immunohistochemistry; p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN MSH2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE REGULATION; CLINICAL FEATURE; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MISMATCH REPAIR; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CARCINOMA;

APOPTOSIS; BASE PAIR MISMATCH; CARRIER PROTEINS; DNA REPAIR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MUTS HOMOLOG 2 PROTEIN; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 33847644588     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR et al: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993.
2. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M and Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell 75: 1027-1038, 1993.
3. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M et al: Mutations of a mutS homolog in hereditary non-polyposis colorectal cancer. Cell 75: 1215-1225, 1993.
4. Jiricny J: Mediating mismatch repair. Nat Genet 24: 6-8, 2000.
5. Hidaka M, Takagi Y, Takano TY and Sekiguchi M: PCNA-MutSalpha-mediated binding of MutLalpha to replicative DNA with mismatched bases to induce apoptosis in human cells. Nucleic Acids Res 33: 5703-5712, 2005.
6. Lee SD and Alani E: Analysis of interactions between mismatch repair initiation factors and the replication processivity factor PCNA. J Mol Biol 355: 175-184, 2006.
7. Adem C, Soderberg CL, Cunningham JM, Reynolds C, Sebo TJ, Thibodeau SN, Hartmann LC and Jenkins RB: Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer 107: 580-582, 2003.
8. Catto JW, Xinarianos G, Burton JL, Meuth M and Hamdy FC: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 105: 484-490, 2003.
9. Parc YR, Halling KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN and Halling AC: Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology. Int J Cancer 86: 60-66, 2000.
10. Spagnoletti I, Pizzi C, Galietta A, Di Maio M, Mastranzo P, Daniele S, Limite G, Pettinato G and Contegiacomo A: Loss of hMSH2 expression in primary breast cancer with p53 alterations. Oncol Rep 11: 845-851, 2004.
11. Friedrich M: Analysis of the DNA "mismatch-repair" enzyme human mut-S-homologon-2 in endometrial cancer on protein-and RNA-level. Eur J Gynaecol Oncol 21: 273-277, 2000.
12. Salvesen HB, MacDonald N, Ryan A, Iversen OE, Jacobs IJ, Akslen LA and Das S: Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 6: 3607-3613, 2000.
13. Friedrich M, Villena-Heinsen C, Meyberg R, Woll-Hermann A, Reitnauer K, Schmidt W, Tilgen W and Reichrath J: Immunohistochemical analysis of DNA "mismatch-repair" enzyme human Mut-S-Homologon-2 in ovarian carcinomas. Histochem J 31: 717-722, 1999.
14. Geisler JP, Goodheart MJ, Sood AK, Holmes RJ, Hatterman-Zogg MA and Buller RE: Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 98: 2199-2206, 2003.
15. Friedrich M, Villena-Heinsen C, Reitnauer K, Schmidt W, Tilgen W and Reichrath J: Malignancies of the uterine corpus and immunoreactivity score of the DNA "mismatch-repair" enzyme human Mut-S-homologon-2. J Histochem Cytochem 47: 113-118, 1999.
16. Balogh GA, Russo IH and Russo J: Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. Int J Oncol 23: 411-419, 2003.
17. Bock N, Meden H, Regenbrecht M, Junemann B, Wangerin J and Marx D: Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast. Anticancer Res 20: 119-124, 2000.
18. Friedrich M, Meyberg R, Villena-Heinsen C, Woll-Hermann A, Reitnauer K, Schmidt W, Tilgen W and Reichrath J: Immunohistochemical analysis of DNA mismatch-repair enzyme hMSH-2 and Ki-67 in breast carcinomas. Anticancer Res 19: 3349-3353, 1999.
19. Giarnieri E, Mancini R, Pisani T, Alderisio M and Vecchione A: Msh2, MIh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 6: 3600-3606, 2000.
20. Ciavattini A, Piccioni M, Tranquilli AL, Filosa A, Pieramici T and Goteri G: Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions. Pathol Res Pract 201: 21-25, 2005.
21. Bhattacharyya N, Chen HC, Grundfest-Broniatowski S and Banerjee S: Alteration of hMSH2 and DNA polymerase beta genes in breast carcinomas and fibroadenomas. Biochem Biophys Res Commun 259: 429-435, 1999.
22. Zhang H, Richards B, Wilson T, Lloyd M, Cranston A, Thorburn A, Fishel R and Meuth M: Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res 59: 3021-3027, 1999.
23. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD and Wang JY: Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci USA 100: 2420-2425, 2003.
24. Clodfelter JE, Gentry MB and Drotschmann K: MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instability. Nucleic Acids Res 33: 3323-3330, 2005.
25. Drotschmann K, Topping RP, Clodfelter JE and Salsbury FR: Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival. DNA Repair (Amst) 3: 729-742, 2004.
26. Scherer SJ, Maier SM, Seifert M, Hanselmann RG, Zang KD, Muller-Hermelink HK, Angel P, Welter C and Schartl M: p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem 275: 37469-37473, 2000.
27. Warnick CT, Dabbas B, Ford CD and Strait KA: Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells. J Biol Chem 276: 27363-27370, 2001.
28. Rass K, Gutwein P, Welter C, Meineke V, Tilgen W and Reichrath J: DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines. Histochem J 33: 459-467, 2001.
29. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987.
30. Thomas DJ, Robinson MC, Charlton R, Wilkinson S, Shenton BK and Neal DE: P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder. Br J Urol 73: 533-537, 1994.
31. Cheah PL and Looi LM: P53 immunohistochemical expression: messages in cervical carcinogenesis. Pathology 34: 326-331, 2002.
32. Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A and Zehbe I: The role of TP53 in Cervical carcinogenesis. Hum Mutat 21: 307-312, 2003.
33. Haensgen G, Krause U, Becker A, Stadler P, Lautenschlaeger C, Wohlrab W, Rath FW, Molls M and Dunst J: Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys 50: 865-872, 2001.
34. Scherer SJ, Seib T, Seitz G, Dooley S and Welter C: Isolation and characterization of the human mismatch repair gene hMSH2 promoter region. Hum Genet 97: 114-116, 1996.
35. Gatz SA and Wiesmuller L: p53 in recombination and repair. Cell Death Differ 13: 1003-1016, 2006.
36. Chung TK, Cheung TH, Wang VW, Yu MY and Wong YF: Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association. Gynecol Obstet Invest 52: 98-103, 2001.